Semaglutide ZPHC — 20 mg (5 vials × 4 mg)

Semaglutide — GLP-1 receptor agonist
5 lyophilised vials × 4 mg (total 20 mg)
Research focus: powerful appetite suppression, delayed gastric emptying, improved insulin sensitivity and rapid fat-loss.
Once-weekly protocol: long half-life allows a single sub-Q injection per week.
Reconstitution: add 2 ml bacteriostatic water → 2 mg/ml; swirl gently, avoid foaming. Store 2 – 8 °C.
Titration guide (research): Week 1-4 → 0.25 mg • Week 5-8 → 0.5 mg • escalate to 1 mg weekly if well-tolerated.
Pharma-grade QC: ≥ 99 % purity, endotoxin < 0.03 EU/mg; each box bears a scratch-code for authenticity.
Cold-chain packed • tamper-evident vials • discreet, tracked worldwide delivery.